These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15867075)

  • 21. Risperidone in young children with pervasive developmental disorders and other developmental disabilities.
    Demb HB
    J Child Adolesc Psychopharmacol; 1996; 6(1):79-80. PubMed ID: 9231302
    [No Abstract]   [Full Text] [Related]  

  • 22. Risperidone and late onset tics.
    Feroz-Nainar C; Roy M
    Autism; 2006 May; 10(3):302-7. PubMed ID: 16682400
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining risperidone use in those diagnosed with autism 1 year after FDA approval.
    Valdovinos MG; Bailey L; Taylor SL
    J Clin Psychiatry; 2010 May; 71(5):651-2. PubMed ID: 20492856
    [No Abstract]   [Full Text] [Related]  

  • 25. Case study: anorexia nervosa and autistic disorder in an adolescent girl.
    Fisman S; Steele M; Short J; Byrne T; Lavallee C
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):937-40. PubMed ID: 8768355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further thoughts on autistic tendencies.
    Pomeroy JC; Friedman C; Stephens L
    Dev Med Child Neurol; 1990 Sep; 32(9):832-3. PubMed ID: 2227146
    [No Abstract]   [Full Text] [Related]  

  • 28. First drug to treat irritability associated with autism.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17342827
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone-induced double incontinence.
    Hergüner S; Mukaddes NM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
    [No Abstract]   [Full Text] [Related]  

  • 30. Risperidone in the treatment of pervasive developmental disorder.
    Purdon SE; Lit W; Labelle A; Jones BD
    Can J Psychiatry; 1994 Sep; 39(7):400-5. PubMed ID: 7527293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone and refusal to eat.
    Schwam JS; Klass E; Alonso C; Perry R
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):572-3. PubMed ID: 9628075
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone and double incontinence in a child with autism.
    Cop E; Oner P; Oner O
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):647-8. PubMed ID: 22136093
    [No Abstract]   [Full Text] [Related]  

  • 33. Does risperidone improve hyperacusia in children with autism?
    Ghanizadeh A
    Psychopharmacol Bull; 2009; 42(1):108-10. PubMed ID: 19204655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone in children with autism and serious behavioral problems.
    Sandler L
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12466518
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone improves behavior in children with autism.
    Caicedo C; Williams SH
    J Fam Pract; 2002 Nov; 51(11):915. PubMed ID: 12485538
    [No Abstract]   [Full Text] [Related]  

  • 36. Pervasive developmental disorders in multiply disabled children.
    Burd L; Fisher W; Kerbeshian J
    Rehabil Lit; 1985; 46(9-10):246-9. PubMed ID: 4070778
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan.
    Satoh M; Obara T; Nishigori H; Ooba N; Morikawa Y; Ishikuro M; Metoki H; Kikuya M; Mano N
    World J Pediatr; 2016 Nov; 12(4):443-449. PubMed ID: 27286689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone in children with autism and serious behavioral problems.
    Munarriz R; Bennett L; Goldstein I
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472072
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.
    Anderson GM; Scahill L; McCracken JT; McDougle CJ; Aman MG; Tierney E; Arnold LE; Martin A; Katsovich L; Posey DJ; Shah B; Vitiello B
    Biol Psychiatry; 2007 Feb; 61(4):545-50. PubMed ID: 16730335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone in the treatment of two very young children with autism.
    Posey DJ; Walsh KH; Wilson GA; McDougle CJ
    J Child Adolesc Psychopharmacol; 1999; 9(4):273-6. PubMed ID: 10630457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.